MIM morbid description	MIM morbid accession
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM;;PLATELET DISORDER, ASPIRIN-LIKE;;THROMBOCYTOPENIA, FAMILIAL, WITH PROPENSITY TO ACUTE MYELOGENOUS LEUKEMIA; FPD/AML	601399
IMERSLUND-GRASBECK SYNDROME 1; IGS1;;MEGALOBLASTIC ANEMIA, FINNISH TYPE;;MEGALOBLASTIC ANEMIA, 1; MGA1;;PERNICIOUS ANEMIA, JUVENILE, DUE TO SELECTIVE INTESTINAL MALABSORPTION OF VITAMIN B12, WITH PROTEINURIA;;ENTEROCYTE COBALAMIN MALABSORPTION;;ENTE /.../ INTRINSIC FACTOR RECEPTOR, DEFECT OF	261100
MAPLE SYRUP URINE DISEASE; MSUD;;BRANCHED-CHAIN KETOACIDURIA;;BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY;;BCKD DEFICIENCY;;KETO ACID DECARBOXYLASE DEFICIENCY MAPLE SYRUP URINE DISEASE, CLASSIC, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTER /.../E, INCLUDED;;MAPLE SYRUP URINE DISEASE, INTERMITTENT, INCLUDED;;MAPLE SYRUP URINE DISEASE, THIAMINE-RESPONSIVE, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IA, INCLUDED; MSUD1A, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE IB, INCLUDED; MSUD1B, INCLUDED;;MAPLE SYRUP URINE DISEASE, TYPE II, INCLUDED; MSUD2, INCLUDED	248600
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1;;MEN I;;ENDOCRINE ADENOMATOSIS, MULTIPLE;;MEA I;;WERMER SYNDROME MEN1 SOMATIC MUTATIONS, INCLUDED	131100
LEUKEMIA, ACUTE MYELOID; AML;;LEUKEMIA, ACUTE MYELOGENOUS LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO, INCLUDED	601626
